Summary
This filing is an amendment (8-K/A) to a previous Current Report on Form 8-K, specifically addressing the election of Lawrence D. Kingsley to the IDEXX Laboratories, Inc. Board of Directors. The amendment clarifies that there are no related-party transactions involving Mr. Kingsley that need to be disclosed under SEC regulations. The core information remains the appointment of Mr. Kingsley as an independent director, effective October 19, 2016, and his subsequent committee assignments, alongside an adjustment to the board size to accommodate this change.
Key Highlights
- 1IDEXX Laboratories appointed Lawrence D. Kingsley as an independent Class II Director to its Board of Directors on October 19, 2016.
- 2Mr. Kingsley has been appointed to serve on the Board's Compensation and Finance Committees.
- 3The total number of directors on the Board was increased from nine to ten to facilitate Mr. Kingsley's appointment.
- 4Mr. Kingsley's term as a Class II Director is expected to align with the 2017 annual meeting of stockholders, with a three-year term expiring in 2020.
- 5This amendment clarifies the absence of any reportable related-person transactions involving Mr. Kingsley.
- 6Mr. Kingsley will receive compensation consistent with other non-employee directors, with prorated fees for the fourth quarter of 2016 and prorated stock grants for his partial service year.
- 7The original report included a press release announcing Mr. Kingsley's election.